HELIOS Klinik Schleswig GmbH

At HELIOS Klinik Schleswig GmbH, clinical trial activity focuses on cardiovascular diseases with a strong emphasis on urgent stroke care. The research is centered on improving outcomes for people affected by acute ischemic stroke and high-risk transient ischemic attack, with studies designed to test new treatment strategies and better protect patients from recurrent events.

• Investigating whether a new therapy can lower the risk of another ischemic stroke after a recent event
• Studying treatment approaches for acute ischemic stroke in patients who recently used direct oral anticoagulants
• Evaluating the effectiveness and safety of thrombolysis to improve recovery after stroke

The trials at this German hospital aim to refine emergency stroke treatment and support better long-term functional outcomes for patients.

This research area addresses acute ischemic stroke care, especially in patients with recent anticoagulant exposure. The studies are focused on determining whether established and emerging treatment strategies can improve recovery, reduce complications, and help clinicians choose the most effective approach in time-sensitive situations.

• Testing a potential therapy to reduce the chance of recurrent stroke after acute ischemic stroke or transient ischemic attack
• Comparing strategies for intravenous thrombolysis in patients who have recently taken direct oral anticoagulants

Overall, the clinical trials at HELIOS Klinik Schleswig GmbH are aimed at improving stroke recovery, treatment safety, and decision-making in emergency neurological care.